RUA Life Sciences PLC

AOHA

Company Profile

  • Business description

    RUA Life Sciences PLC is engaged in contract design and manufacture of medical devices and exploiting the value of its IP and know-how, and developing of cardiovascular devices. Its segments include Biomaterials includes Licensor of Elast-Eon polymers to the medical device industry; Medical Devices and Components engages End-to-end contract developer, manufacturer, and seller of medical devices and implantable fabric specialist; Vascular engages in the development and commercialization of the group’s Elast-Eon sealed Vascular Graft products; and Structural Heart engages in the development of the group’s Elast-Eon composite heart valve material AurTex. Geographically it operates in Europe, North America, Middle East , Asia Pacific, and Africa.

  • Contact

    2 Drummond Crescent
    Ayrshire
    Scotland
    IrvineKA11 5AN
    GBR

    T: +44 1294317073

    E: [email protected]

    https://www.rualifesciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2026

    Employees

    40

Stocks News & Analysis

stocks

Rio Tinto and Glencore go their separate ways

Our view after merger talks end.
stocks

Amazon earnings: Guidance for $200 billion in capital expenditure in 2026 overshadows good results

We think Amazon stock is moderately undervalued.
stocks

Apple earnings: Impressive Q4 lifts stock, but is it a long-term growth play?

We’ve raised our fair value estimate of Apple stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,131.1065.200.72%
CAC 408,273.8435.670.43%
DAX 4024,721.46230.400.94%
Dow JONES (US)50,115.671,206.952.47%
FTSE 10010,369.7560.530.59%
HKSE26,945.35385.401.45%
NASDAQ23,031.21490.632.18%
Nikkei 22556,557.242,303.564.25%
NZX 50 Index13,423.2520.77-0.15%
S&P 5006,932.30133.901.97%
S&P/ASX 2008,871.0060.100.68%
SSE Composite Index4,113.2847.701.17%

Market Movers